Advertisement
Screener

Beyond Air, Inc. (XAIR) Derivative, Gain (Loss) on Derivative, Net

2.8 / 5 stars · 68/120 Roast Me

Beyond Air, Inc. Derivative, Gain (Loss) on Derivative, Net

Beyond Air, Inc. (XAIR) reported Derivative, Gain (Loss) on Derivative, Net of -$1.40 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-26.

Financial Statements › Income Statement › Other Income

us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2026-06-26

  • Beyond Air, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2026-03-31 was -$1.88M.
  • Beyond Air, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2025-12-31 was $483.00K.
  • Beyond Air, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2025-03-31 was $0.00.
  • Beyond Air, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • Beyond Air, Inc. derivative, gain (loss) on derivative, net for fiscal 2026 was -$1.40M, a 206.16% decline from fiscal 2025.
  • Beyond Air, Inc. derivative, gain (loss) on derivative, net for fiscal 2025 was $1.31M, a 2637.50% increase from fiscal 2024.
  • Beyond Air, Inc. derivative, gain (loss) on derivative, net for fiscal 2024 was $48.00K.
Period endDerivative, Gain (Loss) on Derivative, Net 3 monthDerivative, Gain (Loss) on Derivative, Net 6 monthDerivative, Gain (Loss) on Derivative, Net 9 monthDerivative, Gain (Loss) on Derivative, Net 12 month
2026-03-31-$1.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26
-$1.40M
derived: sum of 2 quarters · filed 2026-06-26
-$1.40M
10-K · filed 2026-06-26
2025-12-31$483.00K
10-Q · filed 2026-02-13
$483.00K
10-Q · filed 2026-02-13
2025-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26
$0.00
derived: sum of 2 quarters · filed 2026-06-26
$256.00K
derived: sum of 3 quarters · filed 2026-06-26
$1.31M
10-K · filed 2026-06-26
2024-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13
$256.00K
derived: sum of 2 quarters · filed 2026-02-13
$1.31M
10-Q · filed 2026-02-13
$215.00K
derived: sum of 4 quarters · filed 2026-02-13
2024-09-30$256.00K
10-Q · filed 2025-11-10
$1.31M
10-Q · filed 2025-11-10
$215.00K
derived: sum of 3 quarters · filed 2025-11-10
$350.00K
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30$1.06M
10-Q · filed 2025-08-12
-$41.00K
derived: sum of 2 quarters · filed 2025-08-12
$94.00K
derived: sum of 3 quarters · filed 2025-08-12
$594.00K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20
-$964.00K
derived: sum of 2 quarters · filed 2025-06-20
-$464.00K
derived: sum of 3 quarters · filed 2025-06-20
$48.00K
10-K · filed 2025-06-20
2023-12-31$135.00K
10-Q · filed 2025-02-10
$635.00K
derived: sum of 2 quarters · filed 2025-02-10
$1.15M
10-Q · filed 2025-02-10
2023-09-30$500.00K
10-Q · filed 2024-11-12
$1.01M
10-Q · filed 2024-11-12
2023-06-30$512.00K
10-Q · filed 2024-08-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Tenon Medical, Inc. (TNON)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Profusa, Inc. (PFSA)United States$0.002B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B